- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07267949
Studio Clinico Randomizzato di Fase 2 di AP31969 Versus Placebo per il Controllo del Ritmo nella Fibrillazione Atriale (END-AF-1)
A clinical Randomized Phase 2 Trial of AP31969 versus Placebo for Rhythm Control of Atrial Fibrillation.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
The key goal of this clinical trial is to assess the effectiveness of different doses of AP31969 in lowering Atrial Fibrillation (AF) burden and its safety.
Participants will be randomly assigned to one of the following groups:
- AP31969 at 100 mg, 200 mg, or 350 mg doses
- AP31969 500 mg (not included at the trial start)
- Placebo (inactive treatment and has no active properties). The placebo group serves as the comparator for AP31969. All treatments are given orally, twice daily.
The trial includes 3 periods: screening (up to 4 weeks), treatment (12 weeks), and follow-up (30 days). The duration of the trial for a participant is approximately 20 weeks.
Participants will receive an implantable loop recorder and undergo assessments during the visits at specific times, for example blood and urine analyses, and electrocardiogram.
Tipo di studio
Iscrizione (Stimato)
Fase
- Fase 2
Contatti e Sedi
Contatto studio
- Nome: Birgitte Vestbjerg
- Numero di telefono: +0045 2077 2575
- Email: bve@acesionpharma.com
Luoghi di studio
-
-
PD
-
Plovdiv, PD, Bulgaria, 4002
- Reclutamento
- UMHAT "Sveti Georgi" EAD, Department of Invasive Cardiology
-
-
SOF
-
Sofia, SOF, Bulgaria, 1000
- Reclutamento
- Acibadem City Clinic, Cardiology Department
-
Sofia, SOF, Bulgaria, 1365
- Ritirato
- MHAT National Cardiology Hospital EAD, Cardiology Department
-
Sofia, SOF, Bulgaria, 1431
- Reclutamento
- Aleksandrovska University Hospital, Clinic of Cardiology
-
-
VAR
-
Varna, VAR, Bulgaria, 9000
- Reclutamento
- SHATC Cardiolife, Invasive Cardiology
-
Varna, VAR, Bulgaria, 9020
- Reclutamento
- Medical Center Nova Clinic
-
-
-
-
-
Hellerup, Danimarca, 2730
- Reclutamento
- University Hospital Herlev and Gentofte Department of Cardiology
-
Viborg, Danimarca, 8800
- Reclutamento
- Viborg Hospital, Department of Cardiology
-
-
-
-
-
Coburg, Germania, 96450
- Reclutamento
- Sana Kliniken Oberfranken, Klinikum Coburg Kardiologie und Innere Medizin
-
Frankfurt, Germania, 60590
- Reclutamento
- Universitätsklinikum Frankfurt Medizinische Klinik III - Kardiologie, Angiologie, Hämostaseologie, Nephrologie
-
Hamburg, Germania, 20246
- Reclutamento
- Universitaets Klinikum Hamburg-Eppendorf (UKE Hamburg), Kardiologie
-
-
-
-
-
Milan, Italia, 20162
- Reclutamento
- ASST Grande Ospedale Metropolitano Niguarda Cardiology 3 - Electrophysiology "De Gasperis" Cardio Center
-
Milan, Italia, 20122
- Non ancora reclutamento
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Department of Cardio - Thoracic- Vascular Diseases,
-
Modena, Italia, 30174
- Reclutamento
- University of Modena and Reggio Emilia, Policlinico di Modena, Cardiology Department
-
-
BO
-
Bologna, BO, Italia, 40138
- Reclutamento
- Policlinico Sant'Orsola Cardiology Department
-
-
FE
-
Cona, FE, Italia, 444124
- Reclutamento
- Arcispedale Sant'Anna, Cardiology Department
-
-
VE
-
Mestre, VE, Italia, 30174
- Reclutamento
- Dell'Angelo Hospital, Cardiology Department
-
-
-
-
-
Arnhem, Olanda, 6815 AD
- Reclutamento
- Rijnstate Ziekenhuis, Cardiology Department
-
Deventer, Olanda, 7416 SE
- Reclutamento
- Deventer Ziekenhuis, Cardiology Department
-
Groningen, Olanda, 9728 NT
- Reclutamento
- Martini Hospital Groningen, Cardiology Department
-
Haarlem, Olanda, 2035 RC
- Reclutamento
- Spaarne Gasthuis, Cardiology Department
-
Leeuwarden, Olanda, 8934 AD
- Ritirato
- Frisius MC Leeuwarden, Hart- en Vaatcentrum
-
Maastricht, Olanda, 6229 HX
- Attivo, non reclutante
- Maastricht University Medical Center, Cardiology Department
-
The Hague, Olanda, 2545 AA
- Reclutamento
- HagaZiekenhuis, Cardiology/Electrophysiology Unit
-
Tiel, Olanda, 4002 WP
- Reclutamento
- Rivierenland Hospital, Cardiology Department
-
Veldhoven, Olanda, 5504 DB
- Reclutamento
- Máxima Medisch Centrum, Cardiology Department
-
-
-
-
-
Bydgoszcz, Polonia, 85-231
- Reclutamento
- Centrum Medyczne KERmed Cardiology Department
-
Chrzanów, Polonia, 85-231
- Reclutamento
- Małopolskie Centrum Sercowo-Naczyniowe PAKS Oddział Intensywnej Opieki Kardiologicznej
-
Dąbrowa Górnicza, Polonia, 41-300
- Reclutamento
- Polsko-Amerykańskie Kliniki Serca III Oddział Kardiologii Inwazyjnej, Angiologii i Elektrokardiologii
-
Katowice, Polonia, 40-635
- Non ancora reclutamento
- Upper-Silesian Medical Center 2nd Department of Cardiology
-
Katowice, Polonia, 40-635
- Non ancora reclutamento
- Gornoslaskie Centrum Medyczne im. prof. Leszka Gieca Slaskiego Uniwersytetu Medycznego w Katowicach
-
Szczecin, Polonia, 70-419
- Reclutamento
- One Day Med Sp. z o.o. Clinical Trials Department
-
Tychy, Polonia, 43-100
- Reclutamento
- Polsko-Amerykańskie Kliniki Serca X Oddział Kardiologii Inwazyjnej, Elektrofizjologii i Elektrostymulacji w Tychach im
-
-
-
-
-
Belgrade, Serbia
- Reclutamento
- University Clinical Centre of Serbia Department for Intensive Care in Arrhythmology
-
Belgrade, Serbia
- Reclutamento
- Institute for Cardiovascular Disease "Dedinje" Department for Electrophysiology
-
Kamenitz, Serbia
- Reclutamento
- Institute for Cardiovascular Diseases Vojvodina Department of Interventional Electrophysiology
-
Kragujevac, Serbia
- Reclutamento
- University Clinical Center Kragujevac Clinic of Cardiology (Depar. Electrophysiology)
-
Niš, Serbia
- Reclutamento
- University Clinical Center Nis Clinic for Cardiovascular Diseases Bulevar
-
Užice, Serbia, 33100
- Reclutamento
- Health Center Uzice Cardiology Department
-
-
-
-
-
Budapest, Ungheria, 1122
- Reclutamento
- Semmelweis Egyetem Városmajori Sziv- és Érsebészeti Klinika
-
Budapest, Ungheria, 1023
- Reclutamento
- Budai Irgalmasrendi Kórház
-
Sopron, Ungheria, 9400
- Ritirato
- Soproni Gyógyközpont Soproni Erzsébet Oktató Kórház és Rehabilitációs Intézet
-
Szeged, Ungheria, 6725
- Reclutamento
- Szent-Györgyi Albert Klinikai Központ, Belgyógyászati Klinika
-
Szolnok, Ungheria, 5000
- Reclutamento
- Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház-Rendelőintézet
-
Zalaegerszeg, Ungheria, 8900
- Reclutamento
- Belvárosi Egészségház, Platán Magánklinika
-
-
Hungary
-
Pécs, Hungary, Ungheria, 7622
- Non ancora reclutamento
- Pécsi Tudományegyetem Szivgyógyászati Klinika (Cardiology Clinic, University of Pecs)
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
-
Willing and able to provide written informed consent.
-
Age 18 or older.
-
ECG documented diagnosis of paroxysmal or persistent AF.
-
AF history at screening indicating an expected AF burden of 1-90%, i.e., at least 1 self-terminating AF episode within 4 months prior to the screening visit.
-
AF burden of ≥ 1% and ≤ 90% assessed with an ECG patch device during the screening period prior to the randomisation visit.
-
Investigator and participant agreement to avoid non-trial related rhythm control intervention for the duration of the trial, including:
- Antiarrhythmic drug class I and/or III (including amiodarone)
- Electrical or pharmacological cardioversion
- AF ablation procedure
-
Willing to have a loop recorder implanted.
Exclusion Criteria:
- Prior AF ablation procedure other than pulmonary vein isolation (PVI) only.
- Any of the following events within 4 weeks prior to the screening visit: Myocardial infarction, Unstable angina pectoris, Stroke or transient, ischaemic attack, Percutaneous coronary intervention (PCI), Coronary artery bypass graft (CABG), Peripheral revascularisation procedure.
- Cardiac pacing device e.g. pacemaker and cardiac resynchronization therapy device with atrial or ventricular pacing for > 5% of the time or existing implantable loop recorder.
- Heart failure, New York Heart Association class III (3) or IV (4).
- Left ventricular ejection fraction < 40% based on imaging (e.g. echocardiography) performed within 6 months prior to or during the screening visit.
- Clinically significant valvular heart disease, including severe aortic stenosis, severe mitral regurgitation and/or severe mitral stenosis, in the opinion of the investigator.
- QTc (Fridericia, QTcF) interval > 450 ms for males and > 470 ms for females at screening.
- eGFR <60 mL/min /1.73 m² based on creatine and CKD-EPI formula
- Use of antiarrhythmic drug class I and/or III within 7 days or, for amiodarone, within 3 months prior to the screening visit.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Quadruplicare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: AP31969 100 mg
Tablets, Twice daily, 12 Weeks |
Tablets, Oral, Twice daily. |
|
Sperimentale: AP31969 200 mg
Tablets, Twice daily, 12 Weeks |
Tablets, Oral, Twice daily. |
|
Sperimentale: AP31969 350 mg
Tablets, Twice daily, 12 Weeks |
Tablets, Oral, Twice daily. |
|
Sperimentale: AP31969 500 mg
Tablets, Twice daily, 12 Weeks |
Tablets, Oral, Twice daily. |
|
Comparatore placebo: Placebo
Tablets, Twice daily, 12 Weeks |
Tablets, oral, Twice daily. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Atrial fibrillation burden
Lasso di tempo: From week 2 to week 12
|
Measured through implantable loop recorder. Calculated as the amount of time with AF relative to the amount of time the participant is under observation (expressed as a %). |
From week 2 to week 12
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Number of atrial fibrillation episodes
Lasso di tempo: From week 2 to week 12
|
Measured through implantable loop recorder. |
From week 2 to week 12
|
|
Change from baseline in Atrial Fibrillation Effect on Quality-of-Life
Lasso di tempo: Week 12
|
Patient reported outcome. Reporting on a scale of 1 to 7, where 7 is the worse outcome. |
Week 12
|
|
Number of ventricular tachycardia episodes > 30 seconds of duration
Lasso di tempo: From week 0 to week 12
|
Measured through implantable loop recorder. |
From week 0 to week 12
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- AP31969-M201
- 2025-521377-14-00 (Ctis)
- 2025 (Sovvenzione/contratto NIH degli Stati Uniti)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Qualified external researchers may request access to anonymized data and needed trial documentation. Requests are evaluated on the basis of scientific merit. Any use of and access to the data must respect the privacy of the participants and will only be provided if applicable laws and regulations allow this.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .